Avery Dennison, a global leader in materials science and packaging solutions, showcased its latest pharmaceutical labeling and packaging innovations at the 15th Annual InnoPack Pharma Confex 2026, held on June 18–19 at the Sahara Star Hotel, Mumbai. As the pharmaceutical industry increasingly looks to packaging as a critical enabler of product integrity, traceability and patient safety, the company highlighted solutions designed to support greater transparency and trust across the healthcare value chain.
At the event, Avery Dennison presented a range of pharmaceutical labeling and packaging solutions designed to address some of the sector’s most important priorities, including product security, intelligent traceability and patient safety. The showcase brought together advanced functional materials, RFID-enabled technologies and authentication solutions that reflect how packaging is evolving from a basic identification layer into a more active part of the healthcare ecosystem.
Recognizing its contributions to packaging innovation, Avery Dennison was awarded in the Advance Packaging Material Category at InnoPack Pharma Confex 2026.
Speaking on the occasion, Jitesh Mehta, Senior Director – Marketing, South Asia, Avery Dennison said, “The pharmaceutical industry is increasingly looking at packaging as a strategic tool whether it is strengthening traceability, supporting patient safety or enabling greater visibility across the supply chain. InnoPack Pharma Confex is a valuable platform to connect with the industry on the changing expectations from pharmaceutical packaging. We are pleased that our work was recognized in the Advance Packaging Material Category, and we value the conversations we had with customers, partners and industry stakeholders during the event.”
The event brought together pharmaceutical manufacturers, packaging companies, technology providers and industry experts to discuss advancements shaping the future of pharmaceutical packaging. Conversations throughout the conference highlighted the growing emphasis on digitalization, supply-chain transparency, sustainability and patient-centric packaging solutions.
Avery Dennison engaged with industry stakeholders on how materials science and intelligent identification technologies can help address the evolving needs of the pharmaceutical sector while supporting greater safety, efficiency and trust across the healthcare value chain. Also engaging with customers on how innovation in materials can support the sector’s evolving needs.